| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | UBS reiterates Buy rating on Darden stock ahead of earnings | ||
| Di | Needham reiterates Medtronic stock rating on Scientia deal | ||
| Di | UBS reiterates Neutral rating on Casey's General Stores stock | ||
| Di | UBS cuts National Beverage stock price target on cost pressures | ||
| Di | BofA reiterates Buy on IBM stock, cites agentic AI positioning | ||
| Di | Elanco Animal Health stock reaffirmed at Buy by UBS on innovation momentum | ||
| Di | UBS raises Academy Sports stock price target to $60 on margin outlook | ||
| Di | UBS reiterates Norwegian Cruise Line stock rating after tech update | ||
| Di | Stifel reiterates Ondas Holdings stock rating on revenue beat | ||
| Di | Stifel reiterates Vertex stock rating on kidney drug trial data | ||
| Di | Cosan Q4 2025 slides: debt slashed 46% amid mixed operating results | ||
| Di | Casey's Q3 2026 slides reveal aggressive growth plan amid mixed results | ||
| Di | Custom Truck Q4 2025 slides: record results mask revenue miss concerns | ||
| Di | UNFI Q2 FY26 slides: profitability surges amid strategic revenue reset | ||
| Di | Cantor Fitzgerald raises Neurocrine Bio price target on Ingrezza outlook | ||
| Di | Stifel raises Cullinan Oncology stock price target on autoimmune progress | ||
| Di | Stifel cuts Vail Resorts stock price target on weak snow conditions | ||
| Di | Cantor Fitzgerald reiterates Septerna stock rating on platform value | ||
| Di | Truist cuts Vail Resorts stock price target on earnings miss | ||
| Di | Stifel reiterates DraftKings stock Buy rating on super app strategy | ||
| Di | Truist cuts Accenture stock price target on ecosystem concerns | ||
| Di | Truist cuts Korn/Ferry stock price target on industry multiples | ||
| Di | Morgan Stanley lowers Yeti stock price target to $47 on tariff concerns | ||
| Di | Cantor Fitzgerald reiterates Overweight on LifeMD stock, $15 target | ||
| Di | ABM Q1 2026 slides: revenue beats offset by margin pressure |